TTD_Target_ID	Target_Name	TTD_Drug_ID	Drug_Name	Drug_Highest_Status	Drug_PubchemID	Molecular_Formula	Molecular_Weight	Canonical_SMILES	Activity	Binder_Type
T36121	Proto-oncogene c-Myc	D0U3EP	Resveratrol	Phase 3	445154	C14H12O3	228.24	C1=CC(=CC=C1/C=C/C2=CC(=CC(=C2)O)O)O	IC50 = 60000 nM	Poor binder
T36121	Proto-oncogene c-Myc	B20CAK	Chembl4241092	Investigative	145985926	C22H14N4O2	366.4	C1=CC(=CC=C1C#N)C2=NC(=CC(=C2)C3=CC=C(C=C3)C(=O)N)C4=CN=CO4	IC50 ~ 100000 nM	Poor binder
T36121	Proto-oncogene c-Myc	B32GLC	Chembl4250683	Investigative	145984862	C25H16FN3O	393.4	C1=CC(=CC(=C1)F)C2=CC(=CC(=N2)C3=CC=C(C=C3)C#N)C4=CC=C(C=C4)C(=O)N	IC50 ~ 100000 nM	Poor binder
T36121	Proto-oncogene c-Myc	B3OX0H	Chembl4240576	Investigative	145983013	C23H16N4O2	380.4	C1=COC(=C1)C2=CC(=CC(=N2)C3=CC=C(C=C3)C#N)C4=CC=C(C=C4)C(=O)NN	IC50 ~ 100000 nM	Poor binder
T36121	Proto-oncogene c-Myc	BAY7P1	Chembl4248050	Investigative	145982633	C24H19N3O2	381.4	COC1=CC=C(C=C1)C2=NC(=NC(=C2)C3=CC=C(C=C3)C(=O)N)C4=CC=CC=C4	IC50 ~ 100000 nM	Poor binder
T36121	Proto-oncogene c-Myc	BHD8I2	Chembl4248116	Investigative	145983842	C21H13N3OS2	387.5	C1=COC(=C1)C2=CC(=CC(=N2)C3=CC=C(C=C3)C4=NC=CS4)C5=NC=CS5	IC50 ~ 100000 nM	Poor binder
T36121	Proto-oncogene c-Myc	BLDU30	Chembl4242611	Investigative	145984250	C23H15N5O2	393.4	C1=CC(=CC=C1C#N)C2=CC(=NC(=N2)C3=CC=[N+](C=C3)[O-])C4=CC=C(C=C4)C(=O)N	IC50 ~ 100000 nM	Poor binder
T36121	Proto-oncogene c-Myc	BQ78GP	4-Nitro-N-(2-phenylphenyl)-2,1,3-benzoxadiazol-7-amine	Investigative	2836600	C18H12N4O3	332.3	C1=CC=C(C=C1)C2=CC=CC=C2NC3=CC=C(C4=NON=C34)[N+](=O)[O-]	IC50 = 146000 nM	Poor binder
T36121	Proto-oncogene c-Myc	BQSN52	(Z)-3,4,3',5'-Tetramethoxystilbene	Investigative	46898027	C18H20O4	300.3	COC1=C(C=C(C=C1)/C=C\\C2=CC(=CC(=C2)OC)OC)OC	IC50 = 60000 nM	Poor binder